According to Zen Score, the 3 best healthcare plan stocks to buy right now are:
1. Molina Healthcare (NYSE:MOH)
Molina Healthcare (NYSE:MOH) is the top healthcare plan stock with a Zen Score of 64, which is 24 points higher than the healthcare plan industry average of 40. It passed 21 out of 33 due diligence checks and has strong fundamentals. Molina Healthcare has seen its stock return 20.28% over the past year, overperforming other healthcare plan stocks by 16 percentage points.
Molina Healthcare has an average 1 year
price target of $411.75, an upside of 16.86% from Molina Healthcare's current stock price of $352.35.
Molina Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Molina Healthcare, 50% have issued a Strong Buy rating, 0% have issued a Buy, 37.5% have issued a hold, while 12.5% have issued a Sell rating, and 0% have issued a Strong Sell.
2. Centene (NYSE:CNC)
Centene (NYSE:CNC) is the second best healthcare plan stock with a Zen Score of 53, which is 13 points higher than the healthcare plan industry average of 40. It passed 17 out of 33 due diligence checks and has strong fundamentals. Centene has seen its stock return 14.79% over the past year, overperforming other healthcare plan stocks by 11 percentage points.
Centene has an average 1 year
price target of $91.13, an upside of 18.11% from Centene's current stock price of $77.15.
Centene stock has a consensus Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Centene, 50% have issued a Strong Buy rating, 12.5% have issued a Buy, 37.5% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
3. Humana (NYSE:HUM)
Humana (NYSE:HUM) is the third best healthcare plan stock with a Zen Score of 51, which is 11 points higher than the healthcare plan industry average of 40. It passed 18 out of 38 due diligence checks and has strong fundamentals. Humana has seen its stock lose -35.01% over the past year, underperforming other healthcare plan stocks by -39 percentage points.
Humana has an average 1 year
price target of $403.12, an upside of 18.71% from Humana's current stock price of $339.58.
Humana stock has a consensus Buy recommendation according to Wall Street analysts. Of the 17 analysts covering Humana, 41.18% have issued a Strong Buy rating, 17.65% have issued a Buy, 41.18% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.